Lot No. 161

This tender concerns the procurement of anti-cancer medications, specifically a package comprising six distinct items. The contracting authority is seeking to acquire these essential pharmaceutical products to support cancer treatment programs. The scope of the tender includes the supply of these specific anti-cancer drugs, which are critical for patient care within the healthcare sector. Interested bidders are expected to provide quotations for the entire lot of six positions. Detailed specifications for each of the six anti-cancer medications, including their active ingredients, dosage forms, strengths, and packaging, will be provided in the tender documentation. Suppliers must demonstrate their ability to meet the quality standards and regulatory requirements for pharmaceutical products. The contract will involve the delivery of these medications to designated healthcare facilities. Further details regarding the submission process, evaluation criteria, and contract duration will be outlined in the full tender announcement. This procurement is vital for ensuring the availability of essential anti-cancer therapies.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of PLN 2.2 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.